Monash University and ClinChoice partner on new therapies development
The partnership aims to speed up early-phase clinical development and provide new therapies to patients.
Drug Development
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody
ImmunityBio receives Macau approval for Anktiva combo therapy
BMS secures FDA and EC approvals for Opdivo in Hodgkin Lymphoma
Novartis to acquire SNV4818 from Synnovation
Congruence secures $39.5m to advance small molecule correctors pipeline
R1 Therapeutics raises $77.5m to progress AP306 for hyperphosphatemia
FDA issues CRL to Aldeyra’s reproxalap drug application
